Luteolin Disrupts Keratinocyte–Dendritic Cell Communication in Psoriasis by Targeting Rh Family C Glycoprotein
Mediators of Inflammation · 2026-01 · 2026 (1)
DOI: 10.1155/mi/9564209 ↗Kurz gefasst
Fachartikel in der Zeitschrift Mediators of Inflammation, online erschienen am 12.03.2026. Verfasst von Qian Zhang und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Dermatology, Zhangjiagang TCM Hospital Affiliated to Nanjing University of Chinese Medicine, Zhangjiagang, 215600, Jiangsu, China, njuc…. Hauptthemen laut MEDLINE: Psoriasis, Luteolin, Dendritic Cells, Keratinocytes. Die Arbeit nennt 89 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation for Young Scientists of China, Jiangsu Province Traditional Chinese Medicine Science and Technology Development Plan General Project, Suzhou Applied Basic Research (Medical and Health) Technology Innovation Project.
Abstract (Originalsprache)
Psoriasis, a chronic inflammatory skin disease, arises from a dysregulated interaction between keratinocytes (KCs) and dendritic cells (DCs). We previously identified Rh family C glycoprotein (RHCG) as a key mediator of KC inflammation and DC activation. Here, we demonstrate that luteolin, a bioactive compound derived from the traditional Chinese formula cooling blood and detoxicating formula (CBDF), directly binds to RHCG, as confirmed by multiple computational methods and in vitro experiments. In vitro, luteolin suppressed RHCG expression in KCs, reducing CXCL14 secretion and subsequent DC activation. Spatial transcriptomics (STs) revealed that luteolin preferentially targets DC–enriched spatial domains and restores desmosomal protein expression (e.g., DSC2), which is dysregulated in psoriasis. In vivo, luteolin ameliorated psoriasis‐like inflammation in imiquimod‐induced mice, lowering Psoriasis Area and Severity Index (PASI) scores and normalizing pathological markers. Our findings indicate that luteolin disrupts KC–DC communication through multiple modes of action, thereby reversing tissue‐level pathology and demonstrating its potential as a targeted therapy for psoriasis.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Dermatology, Zhangjiagang TCM Hospital Affiliated to Nanjing University of Chinese Medicine, Zhangjiagang, 215600, Jiangsu, China, njucm.edu.cn.
- People's Hospital of Nanfeng Town, Zhangjiagang, 215600, Jiangsu, China.
- Department of Dermatology, Affiliated Hospital of Nanjing University of Chinese Medicine, Jiangsu Province Hospital of Chinese Medicine, Nanjing, 210029, Jiangsu, China, jshtcm.com.
- Department of Oncology, Affiliated Hospital of Nanjing University of Chinese Medicine, Jiangsu Province Hospital of Chinese Medicine, Nanjing, 210029, Jiangsu, China, jshtcm.com.
- Nord Anglia School Suzhou, Xiangcheng, 215131, Jiangsu, China.
ORCID-Profile: Qian Zhang, Cheng-Cheng Feng, Shun Guo, Chen Ji, Hui Shen
Förderung
- National Natural Science Foundation for Young Scientists of China
- Jiangsu Province Traditional Chinese Medicine Science and Technology Development Plan General Project
- Suzhou Applied Basic Research (Medical and Health) Technology Innovation Project
Zitieren
APA
Zhang, Q., Gao, Y. W., Feng, C. C., Yang, L., Chen, F., Guo, S., Liu, Y. J., Lu, Q. Y., Ji, C., & Shen, H. (2026). Luteolin Disrupts Keratinocyte–Dendritic Cell Communication in Psoriasis by Targeting Rh Family C Glycoprotein. Mediators of Inflammation, 2026(1). https://doi.org/10.1155/mi/9564209
Vancouver
Zhang Q, Gao YW, Feng CC, Yang L, Chen F, Guo S, et al. Luteolin Disrupts Keratinocyte–Dendritic Cell Communication in Psoriasis by Targeting Rh Family C Glycoprotein. Mediators of Inflammation. 2026;2026(1). doi:10.1155/mi/9564209
BibTeX
@article{Zhang2026,
author = {Zhang, Qian and Gao, Yan-Wei and Feng, Cheng-Cheng and Yang, Liang and Chen, Fang and Guo, Shun and Liu, Yuan-Jie and Lu, Qiu-Ya and Ji, Chen and Shen, Hui},
title = {Luteolin Disrupts Keratinocyte–Dendritic Cell Communication in Psoriasis by Targeting Rh Family C Glycoprotein},
journal = {Mediators of Inflammation},
year = {2026},
volume = {2026},
number = {1},
doi = {10.1155/mi/9564209}
}
EUVIMED